Overcoming artefact: anticipation in 284 Portuguese kindreds with familial amyloid polyneuropathy (FAP) ATTRV30M
暂无分享,去创建一个
Teresa Coelho | Jorge Sequeiros | D. Mendonça | A. Sousa | C. Lemos | J. Sequeiros | T. Coelho | Alda Sousa | Carolina Lemos | Miguel Alves-Ferreira | Ana Martins-da-Silva | Denisa Mendonça | M. Alves-Ferreira | Ana Martins-da-Silva
[1] J. E. Friedman. Anticipation in hereditary disease: the history of a biomedical concept , 2011, Human Genetics.
[2] C. Bonaïti‐pellié,et al. Penetrance estimation of TTR familial amyloid polyneuropathy (type I) in Brazilian families , 2009, European journal of neurology.
[3] A. Paterson,et al. Genetic anticipation: fact or artifact, genetics or epigenetics? , 1997, The Lancet.
[4] G. Holmgren,et al. Familial amyloidotic polyneuropathy in Sweden: a pedigree analysis. , 1993, Journal of medical genetics.
[5] Frank Z. Stanczyk,et al. Sex differences in β-amyloid accumulation in 3xTg-AD mice: Role of neonatal sex steroid hormone exposure , 2010, Brain Research.
[6] A. Paterson,et al. Evidence for genetic anticipation in non-Mendelian diseases. , 1996, American journal of human genetics.
[7] S M Breathnach,et al. Amyloid and amyloidosis. , 1988, Journal of the American Academy of Dermatology.
[8] M. Saraiva,et al. Genetic epidemiology of familial amyloid polyneuropathy in the Balearic Islands (Spain) , 2005, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[9] G. Sirugo,et al. Genetic anticipation in Portuguese kindreds with familial amyloidotic polyneuropathy is unlikely to be caused by triplet repeat expansions , 1999, Human Genetics.
[10] A. Sousa,et al. Genetic Study of Late-Onset in Hereditary Amyloid Neuropathy (HAN) — Type I (Portuguese, Andrade) , 1988 .
[11] C. Bonaiti-Pellié,et al. Heterogeneity of penetrance in familial amyloid polyneuropathy, ATTR Val30Met, in the Swedish population , 2008, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[12] Y. Ando,et al. Change in the age of onset in patients with familial amyloidotic polyneuropathy type I. , 1995, Internal medicine.
[13] C ANDRADE,et al. A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. , 1952, Brain : a journal of neurology.
[14] I. Cardoso,et al. Gender-dependent transthyretin modulation of brain amyloid-β levels: evidence from a mouse model of Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.
[15] J. R. Pilsner,et al. DNA methylation in schizophrenia subjects: gender and MTHFR 677C/T genotype differences. , 2012, Epigenomics.
[16] M. MacDonald,et al. Huntington's disease: the case for genetic modifiers , 2009, Genome Medicine.
[17] G. Sobue,et al. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity. , 2002, Neurology.
[18] F. McMahon,et al. Anticipation in bipolar affective disorder. , 1993, American journal of human genetics.
[19] J. Sequeiros,et al. Onset in the seventh decade and lack of symptoms in heterozygotes for the TTRMet30 mutation in hereditary amyloid neuropathy-type I (Portuguese, Andrade). , 1987, American journal of medical genetics.
[20] F. Fraser,et al. Trinucleotide repeats not the only cause of anticipation , 1997, The Lancet.
[21] G. Holmgren,et al. Familial amyloidotic polyneuropathy in Sweden: geographical distribution, age of onset, and prevalence. , 1993, Human heredity.
[22] R. Griggs,et al. Evidence for anticipation and association of deletion size with severity in facioscapulohumerd muscular dystrophy , 1996 .
[23] M. Benson. Pathogenesis of transthyretin amyloidosis , 2012, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[24] N. Yanagisawa,et al. A pedigree analysis with minimised ascertainment bias shows anticipation in Met30-transthyretin related familial amyloid polyneuropathy. , 1998, Journal of medical genetics.
[25] Arturas Petronis,et al. Epigenetic approaches to psychiatric disorders , 2010, Dialogues in clinical neuroscience.
[26] A. Sousa,et al. Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in Póvoa do Varzim and Vila do Conde (north of Portugal). , 1995, American journal of medical genetics.
[27] C. Bonaïti‐pellié,et al. Parent-of-origin effect in transthyretin related amyloid polyneuropathy , 2009, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[28] J. Geraedts,et al. Anticipation in myotonic dystrophy: fact or fiction? , 1989, Brain : a journal of neurology.
[29] G. Winberg,et al. DNA-Encoding Enzymatically Active HIV-1 Reverse Transcriptase, but Not the Inactive Mutant, Confers Resistance to Experimental HIV-1 Challenge , 2001, Intervirology.
[30] L. Penrose. The problem of anticipation in pedigrees of dystrophia myotonica. , 1948, Annals of eugenics.
[31] R. Griggs,et al. Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy. The FSH-DY Group. , 1996, Annals of neurology.
[32] W. Reardon,et al. Anticipation in myotonic dystrophy: new light on an old problem. , 1992, American journal of human genetics.